PPCB
Financials
- Market Capitalization 3.08 M
- Employee 2
- Founded 2007
- CEO N/A
- Website www.propanc.com
- Headquarter Delaware, United States
- FIGI BBG002086386
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4899 |  KAPA Kairos Pharma, Ltd. Common Stock | 0.24 USD | 0.00% | 0.00% | -17.24% | -58.62% | 5.69 M USD | ||
| 4966 |  VIVS VivoSim Labs, Inc. - Common Stock | 0.29 USD | 0.00% | +3.57% | -14.71% | -84.82% | 4.31 M USD | ||
| 5039 |  VBIO Valion Bio, Inc. - Common stock | 0.12 USD | 0.00% | -14.29% | -55.56% | -90.00% | 2.66 M USD | ||
| 5066 |  DCOY Decoy Therapeutics Inc. - Common Stock | 2.90 USD | -2.36% | -9.94% | -30.46% | +258.56% | 1.90 M USD |
Frequently asked questions about Propanc Biopharma, Inc. Common Stock
What is the Propanc Biopharma, Inc. Common Stock stock price today?
The current price of Propanc Biopharma, Inc. Common Stock (PPCB) is 1.35. Over the past 24 hours, the stock has changed by -39.46%. Follow the PPCB chart for real-time price dynamics.
What is the stock ticker of Propanc Biopharma, Inc. Common Stock?
Propanc Biopharma, Inc. Common Stock trades under the ticker PPCB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Propanc Biopharma, Inc. Common Stock stock going up?
PPCB has changed by +19.47% over the last week, +35.00% over the last month, and -54.85% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Propanc Biopharma, Inc. Common Stock?
Propanc Biopharma, Inc. Common Stock currently has a market capitalization of 3.08 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Propanc Biopharma, Inc. Common Stock earnings last quarter?
Last quarter, Propanc Biopharma, Inc. Common Stock reported earnings of -7 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Propanc Biopharma, Inc. Common Stock revenue for the last quarter?
Propanc Biopharma, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Propanc Biopharma, Inc. Common Stock net income for the last quarter?
Propanc Biopharma, Inc. Common Stock reported net income of -6.36 M for the last quarter. The previous quarter showed -3.09 M, which means net income changed by -105.74%.
How many employees does Propanc Biopharma, Inc. Common Stock have?
As of the latest available data, Propanc Biopharma, Inc. Common Stock has 2 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Propanc Biopharma, Inc. Common Stock stock?
You can buy Propanc Biopharma, Inc. Common Stock (PPCB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Propanc Biopharma, Inc. Common Stock stock?
Investing in Propanc Biopharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PPCB chart and related analysis on metatrader.com as part of your research.